These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10124 related articles for article (PubMed ID: 11414560)

  • 1. Bayesian semiparametric models for survival data with a cure fraction.
    Ibrahim JG; Chen MH; Sinha D
    Biometrics; 2001 Jun; 57(2):383-8. PubMed ID: 11414560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian dynamic models for survival data with a cure fraction.
    Kim S; Chen MH; Dey DK; Gamerman D
    Lifetime Data Anal; 2007 Mar; 13(1):17-35. PubMed ID: 17136621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully semiparametric Bayesian approach for modeling survival data with cure fraction.
    Demarqui FN; Dey DK; Loschi RH; Colosimo EA
    Biom J; 2014 Mar; 56(2):198-218. PubMed ID: 24338809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian methods for missing covariates in cure rate models.
    Chen MH; Ibrahim JG; Lipsitz SR
    Lifetime Data Anal; 2002 Jun; 8(2):117-46. PubMed ID: 12048863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On Bayesian inference for proportional hazards models using noninformative priors.
    Kim SW; Ibrahim JG
    Lifetime Data Anal; 2000 Dec; 6(4):331-41. PubMed ID: 11190603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general class of Bayesian survival models with zero and nonzero cure fractions.
    Yin G; Ibrahim JG
    Biometrics; 2005 Jun; 61(2):403-12. PubMed ID: 16011686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data.
    Brown ER; Ibrahim JG
    Biometrics; 2003 Jun; 59(2):221-8. PubMed ID: 12926706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transformation class for spatio-temporal survival data with a cure fraction.
    Hurtado Rúa SM; Dey DK
    Stat Methods Med Res; 2016 Feb; 25(1):167-87. PubMed ID: 22514030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of globally obtained informative priors on bayesian safety performance functions developed for Australian crash data.
    Afghari AP; Haque MM; Washington S; Smyth T
    Accid Anal Prev; 2019 Aug; 129():55-65. PubMed ID: 31108237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum likelihood methods for cure rate models with missing covariates.
    Chen MH; Ibrahim JG
    Biometrics; 2001 Mar; 57(1):43-52. PubMed ID: 11252617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion time cure rate model with nonparametric form of covariate effects.
    Chen T; Du P
    Stat Med; 2018 May; 37(10):1625-1635. PubMed ID: 29341205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian transformation cure frailty models with multivariate failure time data.
    Yin G
    Stat Med; 2008 Dec; 27(28):5929-40. PubMed ID: 18618427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian semiparametric accelerated failure time model.
    Walker S; Mallick BK
    Biometrics; 1999 Jun; 55(2):477-83. PubMed ID: 11318203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic priors for model selection using an encompassing model with applications to censored failure time data.
    Kim SW; Sun D
    Lifetime Data Anal; 2000 Sep; 6(3):251-69. PubMed ID: 10949862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxed Poisson cure rate models.
    Rodrigues J; Cordeiro GM; Cancho VG; Balakrishnan N
    Biom J; 2016 Mar; 58(2):397-415. PubMed ID: 26686485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
    Gupta C; Cobre J; Polpo A; Sinha D
    Biom J; 2016 Sep; 58(5):1164-77. PubMed ID: 27162061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating different approaches to develop informative priors in hierarchical Bayesian safety performance functions.
    Yu R; Abdel-Aty M
    Accid Anal Prev; 2013 Jul; 56():51-8. PubMed ID: 23612558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroscedastic transformation cure regression models.
    Chen CM; Chen CH
    Stat Med; 2016 Jun; 35(14):2359-76. PubMed ID: 26887342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian nonparametric approach to marginal structural models for point treatments and a continuous or survival outcome.
    Roy J; Lum KJ; Daniels MJ
    Biostatistics; 2017 Jan; 18(1):32-47. PubMed ID: 27345532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 507.